Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Saved in:
| Title: | Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). |
|---|---|
| Authors: | Muntner, Paul (AUTHOR), Davis, Barry R (AUTHOR), Cushman, William C (AUTHOR), Bangalore, Sripal (AUTHOR), Calhoun, David A (AUTHOR), Pressel, Sara L (AUTHOR), Black, Henry R (AUTHOR), Kostis, John B (AUTHOR), Probstfield, Jeffrey L (AUTHOR), Whelton, Paul K (AUTHOR), Rahman, Mahboob (AUTHOR), ALLHAT Collaborative Research Group* (CORPORATE AUTHOR) |
| Source: | Hypertension (0194911X). Nov2014, Vol. 64 Issue 5, p1012-1021. |
| Database: | SPORTDiscus with Full Text |
Be the first to leave a comment!
